The Impact of Different Renal Function Measuring Methods on the Dosages of Meropenem, Piperacillin/Tazobactam and Cefepime in Critically Ill Patients
Impacto de distintos métodos de estimación de la función renal en la dosificación de meropenem, piperacilina/tazobactam y cefepima en pacientes críticos
E. Diego del Ríoa,
, D. Soy Munera, L. Gratacós Santanachb, J. Ribas Salaa
Autor para correspondencia
ediegode@gmail.com
Correspondence: Servicio de Farmacia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España.
Correspondence: Servicio de Farmacia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España.
Leído
2347
Vecesse ha leído el artículo
896
Total PDF
1451
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 55 | 12 | 67 |
| 2025 10 | 78 | 21 | 99 |
| 2025 9 | 55 | 17 | 72 |
| 2025 8 | 44 | 23 | 67 |
| 2025 7 | 45 | 29 | 74 |
| 2025 6 | 47 | 14 | 61 |
| 2025 5 | 97 | 15 | 112 |
| 2025 4 | 60 | 14 | 74 |
| 2025 3 | 59 | 13 | 72 |
| 2025 2 | 42 | 20 | 62 |
| 2025 1 | 35 | 19 | 54 |
| 2024 12 | 28 | 10 | 38 |
| 2024 11 | 46 | 39 | 85 |
| 2024 10 | 31 | 18 | 49 |
| 2024 9 | 40 | 13 | 53 |
| 2024 8 | 32 | 23 | 55 |
| 2024 7 | 22 | 19 | 41 |
| 2024 6 | 25 | 8 | 33 |
| 2024 5 | 22 | 9 | 31 |
| 2024 4 | 18 | 7 | 25 |
| 2024 3 | 19 | 10 | 29 |
| 2024 2 | 27 | 13 | 40 |
| 2024 1 | 16 | 13 | 29 |
| 2023 12 | 20 | 11 | 31 |
| 2023 11 | 24 | 17 | 41 |
| 2023 10 | 10 | 6 | 16 |
| 2023 9 | 19 | 18 | 37 |
| 2023 8 | 22 | 3 | 25 |
| 2023 7 | 13 | 5 | 18 |
| 2023 6 | 11 | 2 | 13 |
| 2023 5 | 20 | 9 | 29 |
| 2023 4 | 17 | 15 | 32 |
| 2023 3 | 12 | 24 | 36 |
| 2023 2 | 7 | 9 | 16 |
| 2022 1 | 4 | 3 | 7 |
| 2022 12 | 8 | 0 | 8 |
| 2022 11 | 12 | 4 | 16 |
| 2022 10 | 3 | 4 | 7 |
| 2022 9 | 6 | 13 | 19 |
| 2022 8 | 9 | 8 | 17 |
| 2022 7 | 10 | 8 | 18 |
| 2022 6 | 18 | 11 | 29 |
| 2022 5 | 4 | 2 | 6 |
| 2022 4 | 8 | 7 | 15 |
| 2022 3 | 8 | 4 | 12 |
| 2022 2 | 4 | 4 | 8 |
| 2021 1 | 4 | 3 | 7 |
| 2021 12 | 5 | 10 | 15 |
| 2021 11 | 5 | 8 | 13 |
| 2021 10 | 5 | 5 | 10 |
| 2021 9 | 4 | 8 | 12 |
| 2021 8 | 5 | 8 | 13 |
| 2021 7 | 9 | 9 | 18 |
| 2021 6 | 5 | 4 | 9 |
| 2021 5 | 8 | 6 | 14 |
| 2021 4 | 15 | 5 | 20 |
| 2021 3 | 5 | 9 | 14 |
| 2021 2 | 4 | 7 | 11 |
| 2020 1 | 2 | 4 | 6 |
| 2020 12 | 2 | 3 | 5 |
| 2020 11 | 5 | 5 | 10 |
| 2020 10 | 4 | 4 | 8 |
| 2020 9 | 3 | 4 | 7 |
| 2020 8 | 7 | 3 | 10 |
| 2020 7 | 6 | 0 | 6 |
| 2020 6 | 1 | 5 | 6 |
| 2020 5 | 4 | 4 | 8 |
| 2020 4 | 1 | 1 | 2 |
| 2020 3 | 3 | 3 | 6 |
| 2020 2 | 3 | 2 | 5 |
| 2020 1 | 1 | 7 | 8 |
| 2019 12 | 4 | 3 | 7 |
| 2019 11 | 3 | 4 | 7 |
| 2019 10 | 2 | 2 | 4 |
| 2019 9 | 6 | 6 | 12 |
| 2019 8 | 0 | 2 | 2 |
| 2019 7 | 3 | 6 | 9 |
| 2019 6 | 1 | 13 | 14 |
| 2019 5 | 9 | 54 | 63 |
| 2019 4 | 2 | 20 | 22 |
| 2019 2 | 0 | 2 | 2 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 1 | 6 | 7 |
| 2018 11 | 0 | 4 | 4 |
| 2018 10 | 2 | 9 | 11 |
| 2018 9 | 7 | 1 | 8 |
| 2018 8 | 5 | 9 | 14 |
| 2018 7 | 7 | 0 | 7 |
| 2018 6 | 1 | 3 | 4 |
| 2018 5 | 0 | 3 | 3 |
| 2018 4 | 2 | 2 | 4 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 1 | 1 | 2 |
| 2018 1 | 1 | 0 | 1 |
| 2017 12 | 2 | 4 | 6 |
| 2017 11 | 2 | 4 | 6 |
| 2017 10 | 1 | 1 | 2 |
| 2017 9 | 2 | 1 | 3 |
| 2017 8 | 3 | 2 | 5 |
| 2017 7 | 0 | 2 | 2 |
| 2017 6 | 6 | 6 | 12 |
| 2017 5 | 7 | 1 | 8 |
| 2017 4 | 8 | 1 | 9 |
| 2017 3 | 11 | 22 | 33 |
| 2017 2 | 8 | 5 | 13 |
| 2016 1 | 2 | 0 | 2 |
| 2016 12 | 2 | 0 | 2 |
| 2016 11 | 0 | 1 | 1 |
| 2016 10 | 3 | 0 | 3 |
| 2016 9 | 2 | 0 | 2 |
| 2016 8 | 7 | 1 | 8 |
Mostrar todo
